Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1880 studies found for:    "Hepatitis, Viral, Human"
Show Display Options
Rank Status Study
21 Completed Prospective Study of HIV Infection in Hemophiliacs
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections;   Blood Disease;   Hemophilia A;   Hepatitis, Viral, Human;   Blood Transfusion;   Cytomegalovirus Infections
Intervention:
22 Completed Risk of Post Transfusion Hepatitis C Virus Infection
Conditions: Hepatitis, Viral, Human;   Blood Transfusion;   Blood Donors
Intervention:
23 Completed Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
24 Completed Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
25 Recruiting Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus Infection
Interventions: Drug: GS-9857;   Drug: Placebo to match GS-9857
26 Approved for marketing Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition: Post-transplant Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Pegylated Interferon
27 Withdrawn Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention:
28 Completed Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ypeginterferon alfa-2b;   Drug: Peginterferon alfa-2a
29 Completed
Has Results
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
30 Completed Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
31 Completed
Has Results
Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
Condition: Hepatitis C
Interventions: Drug: SOF;   Drug: PEG;   Drug: RBV
32 Completed
Has Results
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Condition: Chronic Hepatitis C Virus
Interventions: Drug: LDV/SOF;   Drug: RBV
33 Completed Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Virus Diseases
Intervention: Drug: peginterferon alfa-2a and ribavirin
34 Completed
Has Results
Safety, Tolerability and Efficacy of 12-weeks of Sovaprevir, ACH-3102 and Ribavirin in Treatment-naive GT-1 HCV Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: Sovaprevir;   Drug: ACH-3102;   Drug: RBV;   Drug: Placebo
35 Recruiting Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
Condition: Hepatitis C
Interventions: Drug: DCV/ASV/BMS-791325;   Drug: DCV/ASV/BMS-791325 + RBV
36 Completed Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
37 Completed Qidong Hepatitis B Intervention Study
Conditions: Hepatitis B;   Liver Neoplasms;   Liver Diseases
Intervention: Biological: Hep-V Vax
38 Completed
Has Results
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
Conditions: Chronic Hepatitis C;   Cirrhosis, Liver;   Fibrosis, Liver;   Hepatic Cirrhosis
Interventions: Drug: Peginterferon alfa-2a + Ribavirin;   Drug: Peginterferon alfa-2a
39 Completed A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone
Condition: Hepatitis C
Interventions: Drug: TMC435;   Other: Methadone
40 Terminated
Has Results
Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders
Condition: Hepatitis C
Interventions: Drug: CTS-1027;   Drug: pegylated interferon;   Drug: Ribavirin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years